Gefitinib CAS 184475-35-2: Your Source for Advanced Pharmaceutical Intermediates
Discover the key applications and benefits of this vital compound in cancer therapy research and production.
Get a Quote & SampleProduct Core Value
Gefitinib
Gefitinib (CAS: 184475-35-2) is a vital pharmaceutical intermediate essential for the synthesis of treatments targeting Non-Small Cell Lung Cancer. Its mechanism as a protein kinase inhibitor makes it a cornerstone in modern oncology drug development.
- Explore the efficacy of Gefitinib in Non-Small Cell Lung Cancer treatment, leveraging its kinase inhibitory properties.
- Understand the chemical profile, including its N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine structure and 446.902 molecular weight.
- Learn about potential therapeutic considerations, such as the observed instances of Gefitinib liver injury side effects.
- Source high-quality Gefitinib, available as a white to beige powder, for your pharmaceutical synthesis needs.
Advantages of Using Gefitinib
Targeted Therapy Efficacy
Utilizing Gefitinib pharmaceutical intermediate allows for the development of targeted therapies, specifically focusing on inhibiting protein kinases that drive cancer growth, enhancing treatment precision.
Advanced Cancer Treatment Role
As a key component in treatments for Non-Small Cell Lung Cancer, Gefitinib plays a critical role in improving patient outcomes and offering new therapeutic avenues.
Chemical Purity and Stability
Sourced and processed with care, Gefitinib CAS 184475-35-2 is provided with high purity, ensuring reliable results in complex drug synthesis procedures.
Key Applications
Oncology Treatment
The primary application for Gefitinib pharmaceutical intermediate is in the synthesis of drugs used for the treatment of advanced or metastatic Non-Small Cell Lung Cancer.
Pharmaceutical Synthesis
It serves as a crucial building block in the complex process of manufacturing Active Pharmaceutical Ingredients (APIs) within the pharmaceutical industry.
Kinase Inhibitor Research
Researchers leverage Gefitinib to study and develop new kinase inhibitors, expanding the understanding of cancer biology and drug resistance mechanisms.
Medical Chemistry Studies
This compound is invaluable for medical chemistry studies, aiding in the design and optimization of novel therapeutic agents for various diseases.